Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay

Fig. 3

Quantitative RT-PCR analysis for CD86, COL I, FN, αSMA, TGFβ, and S100A4 gene expression in cultured systemic sclerosis (SSc) and healthy subject (HS) fibroblasts after 24 and 48 h of CTLA4-Ig treatments. Quantitative RT-PCR analysis for CD86, COL I, FN, αSMA, TGFβ, and S100A4 gene expression in cultures of SSc and HS fibroblasts either untreated (CNT) or treated for 24 h (a) and 48 h (b) with CTLA4-Ig at various doses (10, 50, 100, and 500 μg/ml). *p < 0.05, **p < 0.01

Back to article page